Essential Hypertension
Conditions
Interventions
Treatment group :Remote ischemic preconditioning
sham controlled group :sham controlled treatment
Sponsors
Department of Hypertension and Vascular Disease, the First Affiliated Hospital of Sun Yat-Sen University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Patients between 18 and 80 years old with essential hypertension; 2. Patients with grade 1 blood pressure rise or normal high value; 3. Subjects without smoking history or quitting smoking for more than one year; 4. Subjects without history of psychotropic drug use; 5. Subjects without caffeine intake during the study period; 6. Patients who signed informed consent and were willing to cooperate with the study.
Exclusion criteria
Exclusion criteria: 1. Patients with limb fracture, trauma, infection, arteriovenous fistula, etc; 2. Pregnant or lactating women; 3. Subjects with history of coronary heart disease, valvular heart disease, heart failure, diabetes, peripheral vascular disease, or patients with active inflammatory disease, malignant tumor and other serious diseases requiring treatment (such as acute liver disease, chronic renal failure, etc.); 4. Those patients with splenectomy; 5. Those patients who are not conducive to long-term follow-up or poor compliance; 6. Patients considered unsuitable for the trial by the researchers.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Office Blood Pressure; | — |
Countries
China
Contacts
Public ContactJun Tao
Department of Hypertension and Vascular Disease, the First Affiliated Hospital of Sun Yat-Sen University
Outcome results
None listed